Menu
Recruiting NCT07544264

Evaluation of 5-year Survival and Clinical Outcomes in Patients Undergoing Total Knee Arthroplasty With a Polyethylene Tibial Component

No phase Interventional Prosthesis Survival Arthropathy of Knee

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Total knee arthroplasty.
Who it may be relevant to
Registry conditions: Prosthesis Survival, Arthropathy of Knee. Basic parameters: 50 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Total knee arthroplasty (TKA) is one of the most successful procedures in orthopedic surgery for treating advanced knee osteoarthritis, providing pain relief, functional recovery, and improved quality of life. Advances in implant design and materials have further enhanced joint kinematics and patient satisfaction. An aging population has increased the number of elderly patients with comorbidities, potentially affecting surgical outcomes and implant longevity. Polyethylene has long been used in knee prostheses; early all-polyethylene tibial components were abandoned due to high wear and failure rates, in favor of metal-backed designs, which became the gold standard. Recently, highly cross-linked ultra-high-molecular-weight polyethylene (UHMWPE) has renewed interest in all-polyethylene tibial components, although their use remains limited. These implants offer potential advantages, including elimination of locking mechanism failures, reduced backside wear, lower costs, and possibly better load distribution. Evidence from registries, systematic reviews, and meta-analyses shows that 15-year survival of all-polyethylene tibial components is comparable or even superior to metal-backed designs, with no significant differences in clinical-functional outcomes. Additionally, all-poly components are significantly less expensive. Given these findings, increasing their use and evaluating outcomes in Italy is warranted. The aim of the present study is to assess implant survival of the Link Symphoknee prosthesis with an all-polyethylene tibial component, along with clinical-functional outcomes and post-discharge readmission rates in patients treated at the Rizzoli Orthopaedic Institute.

Interventions

  • Device Total knee arthroplasty
    Implantation of the Link Symphoknee prosthesis with an all-polyethylene tibial component

Primary outcome measures

  • Implant failure [Time frame: Up to 5 years post-surgery]
Secondary outcome measures (5)
  • Knee injury and Osteoarthritis Outcome Score (KOOS) [Time frame: Up to 5 years post-surgery]
  • Forgotten Joint Score (FJS) [Time frame: Up to 5 years post-surgery]
  • Visual Analog Scale (VAS) pain [Time frame: Up to 5 years post-surgery]
  • VAS Satisfaction [Time frame: Up to 5 years post-surgery]
  • Hip-Knee-Ankle angle (HKA) [Time frame: Up to 5 years post-surgery]

Eligibility criteria

Inclusion criteria

  • Male and female subjects aged ≥50 and ≤85 years who are candidates for primary cemented total knee arthroplasty based on physical examination and medical history, including a diagnosis of severe knee pain and disability due to at least one of the following conditions:
  • Primary or secondary osteoarthritis
  • Collagen disorders and/or avascular necrosis of the femoral condyle
  • Moderate valgus, varus, or flexion deformities (Hip-Knee-Ankle angle within ±15°).
  • Patients who provide consent and are able to complete the scheduled study procedures and follow-up assessments.
  • Patients who sign the informed consent approved by the Ethics Committee.

Exclusion criteria

  • Patients under 50 years of age and over 85 years of age;
  • Diagnosis of rheumatoid arthritis;
  • Patients with a contralateral joint prosthesis on the same side;
  • Coronal plane deformity with a Hip-Knee-Ankle (HKA) angle greater than 15 degrees in varus or valgus.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Italy · 1 center
  • IRCCS Rizzoli Orthopedic Institute — Bologna

Identifiers

NCT: NCT07544264 · ALLPOLY-TKA

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗